Shouyao Holdings (Beijing) Co. Ltd.

Shouyao Holdings (Beijing) Co. saw a notable increase in its stock performance on March 27, 2026, reaching an intraday high of CNY 39.49. The company has demonstrated resilience over various time frames, outperforming the broader market despite facing challenges such as low return on capital and negative net worth.

Shouyao Holdings (Beijing) Co. faced a notable decline in stock performance, with significant decreases over the past week and month. The company, categorized as small-cap in the pharmaceuticals sector, has reported negative financial metrics, including a negative return on equity and declining net sales over five years.

Shouyao Holdings (Beijing) Co. faced a notable decline in stock value, reflecting ongoing challenges within the company. Despite a year-to-date gain, its longer-term performance raises concerns, with significant losses, a low return on capital employed, and declining net sales over the past five years. The company operates in the Pharmaceuticals & Biotechnology sector.